Leslie-Miller Calissa J, Goltz Shellen R, Barrios Pamela L, Cushing Christopher C, Badshah Teena, Ungaro Corey T, Qu Shankang, Berezhnaya Yulia, Brisbois Tristin D
Department of Clinical Child Psychology, University of Kansas, Lawrence, KS, United States.
Life Sciences, Global R&D, PepsiCo Inc, 700 Anderson Hill Rd, Purchase, NY, 10577, United States.
JMIR Form Res. 2025 May 14;9:e63471. doi: 10.2196/63471.
There is significant global interest in promoting wellness, with digital solutions like mobile health apps being broadly downloaded; yet, there is a challenge in maintaining engagement for long-term behavior change. Developing a widely accepted mobile wellness app is imperative for advancing personalized wellness interventions.
The primary objective of this study was to evaluate the Aspire2B wellness app (powered by Salus Optima), designed to exceed industry standards for participant engagement by incorporating evidence-based behavior change strategies and to assess its acceptability (eg, liking the face scan) and utility (eg, willing to use the face scan technology for other health insights) as a digital health solution.
Participants aged 18-65 years, who were smartphone and fitness tracker users, were recruited in the United States during March-May 2022. Participants received US $5 compensation for downloading the app, with no further incentive for usage. Following completion of onboarding (ie, survey questions about lifestyle behaviors), participants were placed in either a nutrition, sleep, or fitness 4-week challenge. During the challenge, participants used various app features at their own will, such as a facial scan for wellness insights (eg, heart rate and biological age), recipes, and workout videos. These interactions with the app were cumulatively evaluated as engagement metrics. Participants were also asked to answer offboarding questions to evaluate any changes to lifestyle behaviors and experience using the app features (eg, acceptability of face scan experience).
Out of the 398 people who created an account, 85.9% (342/398) completed onboarding and a face scan. Following this, 74.9% (298/398) of users completed additional survey questions about current wellness behaviors. Notably, interaction with the app was relatively stable from week 2 to 4 (173/398, 43.5%), outperforming industry standards by roughly 3×. In addition, on average, participants completed 2.1-2.7 face scans per week, with approximately 7% (24/342) of participants maintaining regular use of face scan technology for 4 weeks. In users who completed offboarding questions, 88.8% (111/125) found Aspire2B credible, 64.8% (81/125) liked the face scan experience, 7.2% (9/125) disliked the face scan experience, and 83.2% (104/125) said they would use face scan technology for other insights into their health.
These findings highlight strong initial engagement with Aspire2B, followed by significant sustained user engagement over a 4-week period. Furthermore, users indicated high levels of credibility and willingness to use face scan technology for wellness insights. These findings collectively demonstrate the capability of a personalized wellness app using AI-enabled digital biomarkers and evidence-supported behavior change techniques to yield positive user perception and provide long-term engagement.
全球对促进健康有着浓厚兴趣,移动健康应用等数字解决方案被广泛下载;然而,要保持用户参与度以实现长期行为改变面临挑战。开发一款被广泛接受的移动健康应用对于推进个性化健康干预至关重要。
本研究的主要目的是评估Aspire2B健康应用(由Salus Optima提供支持),该应用旨在通过纳入基于证据的行为改变策略来超越行业参与者参与度标准,并评估其作为数字健康解决方案的可接受性(如喜欢面部扫描)和实用性(如愿意使用面部扫描技术获取其他健康见解)。
2022年3月至5月在美国招募了年龄在18 - 65岁、使用智能手机和健身追踪器的参与者。参与者下载应用可获得5美元报酬,使用无额外激励。完成入职流程(即关于生活方式行为的调查问卷)后,参与者被分配到营养、睡眠或健身为期4周的挑战中。在挑战期间,参与者可自行使用各种应用功能,如通过面部扫描获取健康见解(如心率和生理年龄)、食谱和锻炼视频。与应用的这些互动被累积评估为参与度指标。还要求参与者回答离职问题,以评估生活方式行为的任何变化以及使用应用功能的体验(如面部扫描体验的可接受性)。
在创建账户的398人中,85.9%(342/398)完成了入职流程和面部扫描。此后,74.9%(298/398)的用户完成了关于当前健康行为的其他调查问卷。值得注意的是,从第2周到第4周与应用的互动相对稳定(173/398,43.5%),比行业标准高出约3倍。此外,参与者平均每周完成2.1 - 2.7次面部扫描,约7%(24/342)的参与者连续4周定期使用面部扫描技术。在完成离职问题的用户中,88.8%(111/125)认为Aspire2B可信,64.8%(81/125)喜欢面部扫描体验,7.2%(9/125)不喜欢面部扫描体验,83.2%(104/125)表示会使用面部扫描技术获取其他健康见解。
这些发现凸显了用户对Aspire2B的高度初始参与度,随后在4周内保持了显著的持续用户参与度。此外,用户表示对使用面部扫描技术获取健康见解具有高度可信度和意愿。这些发现共同证明了一款使用人工智能数字生物标志物和证据支持的行为改变技术的个性化健康应用能够产生积极的用户认知并提供长期参与度。